Correlation Between Acrivon Therapeutics, and Cerevel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Acrivon Therapeutics, and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Cerevel Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Cerevel Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acrivon and Cerevel is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Cerevel Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Cerevel Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.96 times more return on investment than Cerevel Therapeutics. However, Acrivon Therapeutics, Common is 1.04 times less risky than Cerevel Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Cerevel Therapeutics Holdings is currently generating about -0.03 per unit of risk. If you would invest 1,228 in Acrivon Therapeutics, Common on August 27, 2024 and sell it today you would lose (573.00) from holding Acrivon Therapeutics, Common or give up 46.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 78.55% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Cerevel Therapeutics Holdings
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Cerevel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acrivon Therapeutics, and Cerevel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Cerevel Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
| Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |